Muscular Dystrophy, Facioscapulohumeral: all 79 studies

Page 1 of 1. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.

• A Study of SAT-3247 to Evaluate the Safety, Tolerability, and Efficacy in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)Not yet recruitingNCT07872306Phase 2
• A Trial to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of SFL-0821 in Adults With FSHDRecruitingNCT07798609Phase 1/2
• Amino Acids and Exercise in FSHDRecruitingNCT07543016Not applicable
• Phase 2 Study Evaluating Apitegromab for the Treatment of FSHDRecruitingNCT07435129Phase 2
• BetterLife FSHD: A Patient-driven Health and Research PlatformRecruitingNCT07409142
• Imaging and Gait Analysis in FSHD PatientsEnrolling by invitationNCT07164937
• Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic PathologyRecruitingNCT07136844Not applicable
• Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)RecruitingNCT07086521Phase 1
• The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.Enrolling by invitationNCT07072676Not applicable
• A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHDRecruitingNCT07038200Phase 3
• Muscle MRI Outlining of Neuromuscular Diseases Using Artificial IntelligenceNot yet recruitingNCT06917430
• Ten Year Follow-up in FSHD: the FOCUS 3 StudyRecruitingNCT06911190
• Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)RecruitingNCT06847282
• Clenbuterol to Target DUX4 in FSHDRecruitingNCT06721299Phase 1
• Personalized Training for People With Rare Neuromuscular DisordersRecruitingNCT06708468Not applicable
• Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular DisordersEnrolling by invitationNCT06605612
• Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]RecruitingNCT06378203Not applicable
• Magnetic Resonance Imaging and Ultrasound Comparison With Load EvaluationRecruitingNCT06227182
• Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1Enrolling by invitationNCT06131983Phase 1/2
• Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through MetabolomicsNot yet recruitingNCT06086548
• An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease ProgressionRecruitingNCT06079567Not applicable
• Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next StudyRecruitingNCT05982119Not applicable
• Biomarker Development for Muscular DystrophiesRecruitingNCT05019625
• A Registered Cohort Study on FSHD1RecruitingNCT04369209
• The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient RegistryRecruitingNCT04001582
• Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy RegistryRecruitingNCT00082108
• Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)TerminatedNCT05397470Phase 3Results posted
• Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)TerminatedNCT04264442Phase 2Results posted
• Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)CompletedNCT04003974Phase 2Results posted
• Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)TerminatedNCT03943290Phase 2Results posted
• Study of Testosterone and rHGH in FSHDCompletedNCT03123913Phase 1Results posted
• Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)TerminatedNCT02927080Phase 2Results posted
• Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)CompletedNCT02836418Phase 1/2Results posted
• Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular DystrophyCompletedNCT02603562Phase 1/2Results posted
• Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)CompletedNCT02579239Phase 1/2Results posted
• Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study ExtensionCompletedNCT02531217Phase 1/2Results posted
• Bone Health in Facioscapulohumeral Muscular DystrophyCompletedNCT02413190Results posted
• Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular DystrophyCompletedNCT02239224Phase 1/2Results posted
• Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular DiseaseActive, not recruitingNCT07478172Not applicable
• Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity FindingsCompletedNCT07331025
• A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular DystrophyActive, not recruitingNCT06907875Phase 1/2
• Dietary Protein Requirements in Adults With Facioscapulohumeral Muscular DystrophyCompletedNCT06785428Not applicable
• Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)Active, not recruitingNCT06547216Phase 2
• Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular DystrophyStatus unknownNCT06517498
• Quantitative Assessment of Orofacial Muscle Function in FSHDCompletedNCT06425445Not applicable
• The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular DisorderCompletedNCT06363357Not applicable
• Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1Active, not recruitingNCT06222827Phase 2
• FSHD Molecular CharacterizationTerminatedNCT06096441
• The Risk of Falls Index for Patients With Neuromuscular DisordersCompletedNCT05890833
• New Clinical Outcome Measures to Remotely Evaluate Patients With FacioScapuloHumeral Muscular DystrophyCompletedNCT05812144Not applicable
• Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)CompletedNCT05747924Phase 1/2
• A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular DystrophyCompletedNCT05548556Phase 2
• ADVANCED FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot StudyActive, not recruitingNCT05453461Not applicable
• Understanding Control and Mechanisms of Shoulder Instability in FSHDCompletedNCT05239520
• Effectiveness of Upper Extremity Rehabilitation in pwFSHD (Patient With Facioscapulohumeral Dystrophia)CompletedNCT05178706
• Examination of Operative Approach in pwFSHD (Patient With Facioscapulohumeral Muscular Dystrophy)CompletedNCT05022355
• Digital Biotyping of FSHD Patients and ControlsCompletedNCT04999735
• Computerized Facial Recognition for Automated Diagnosis of the Facio-Scapulo-Humeral Muscular Dystrophy (FSMHD)CompletedNCT04377217Not applicable
• Arm Cycling in Facioscapulohumeral Dystrophy (FSHD) PatientsCompletedNCT04267354Not applicable
• Evaluation of a Textile Scapula OrthosisCompletedNCT04154098Not applicable
• Clinical Trial Readiness to Solve Barriers to Drug Development in FSHDActive, not recruitingNCT03458832
• Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHDCompletedNCT02948244Not applicable
• Acceptance and Commitment Therapy for Muscle DiseaseCompletedNCT02810028Not applicable
• Rasch-analysis of Clinical Severity in FSHDCompletedNCT02766985
• Facioscapulohumeral Dystrophy in ChildrenCompletedNCT02625662
• High Intensity Training in Patients With Facioscapulohumeral Muscular DystrophyCompletedNCT02159963Not applicable
• 1 Year MRI Followup in Facioscapulohumeral Muscular DystrophyCompletedNCT02159612
• Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2CompletedNCT02032979Not applicable
• Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2CompletedNCT01970735Not applicable
• At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
• Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With FSHD : Tolerance, Sustainability and Efficiency of Unsupervised Training Program.CompletedNCT01689480
• Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular DystrophyActive, not recruitingNCT01671865
• Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD)CompletedNCT01596803Not applicable
• A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHDCompletedNCT01437345
• Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy PatientsCompletedNCT01116570Not applicable
• Electrostimulation of Shoulder Girdle and Quadriceps Muscles in Facioscapulohumeral Muscular Dystrophy PatientsCompletedNCT00821548Not applicable
• Study Evaluating MYO-029 in Adult Muscular DystrophyCompletedNCT00104078Phase 1/2
• Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic DystrophyCompletedNCT00004769
• Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular DystrophyCompletedNCT00004685Not applicable

← Muscular Dystrophy, Facioscapulohumeral overview